戻る
Algernon Health Inc. (AGNPF)価格
AGNPF 株価推移チャート
AGNPF 収入
Algernon Health Inc.
$0.04
0%
$0
終値： Jan 21, 16:00:00 GMT-5
$0.04
0%
$0
プレマーケット： Jan 22, 07:06:21 GMT-5
主要データ
前終値
$0.04
始値
$0.043
当日レンジ
$0.04 - $0.043
52週レンジ
$0.0346 - $0.09
取引高
22.0K
平均取引高
8.4K
1株当たり利益(TTM)
-0.04
配当利回り
--
時価総額
$1.7M
Algernon Pharmaceuticals Inc.とは何ですか？
Algernon Health Inc is a CA-based company operating in industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2016-02-01. Algernon Health Inc., formerly Algernon Pharmaceuticals Inc., is a Canadian healthcare company. The firm is focused on the provision of brain-specific PET scanning services through a planned network of new clinics in North America for the early-stage detection of Alzheimer’s disease, as well as other forms of dementia, epilepsy, neuro-oncology, and movement disorders. The company is also the parent company of a private subsidiary called Algernon NeuroScience that has been advancing a psychedelic program investigating a proprietary form of DMT for stroke and traumatic brain injury recovery. The firm also owns a 20% equity position in Seyltx, a private U.S-based drug development company advancing a chronic cough drug called Ifenprodil.